Understanding nicotine and tobacco addiction /
Saved in:
| Meeting name: | Symposium on Understanding Nicotine and Tobacco Addiction (2005 : Novartis Foundation) |
|---|---|
| Imprint: | Chichester, UK ; Hoboken, NJ : John Wiley & Sons, 2006. |
| Description: | viii, 275 p. : ill. ; 23 cm. |
| Language: | English |
| Series: | Novartis Foundation symposium ; 275 |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/6011485 |
Table of Contents:
- Symposium on Understanding nicotine and tobacco addiction, held at the Novartis Foundation, London, 17-19 May 2005
- Editors: Gregory Bock (Organizer) and Jamie Goode
- This symposium is based on a proposal made by Robert West and Gino van Heeke
- Chair's introduction
- The hazards of smoking and the benefits of stopping
- Discussion
- Animal models for nicotine dependence
- Discussion
- Defining and assessing nicotine dependence in humans
- Discussion
- General discussion I.
- Nicotinic acetylcholine receptor functions in the CNS investigated with a novel method of stereotaxic gene re-expression in knockout mice
- Discussion
- Nicotine-mediated activation of signal transduction pathways
- Discussion
- Complementary roles for the accumbal shell and core in nicotine dependence
- Discussion
- The dopamine D[subscript 3] system: new opportunities for dopamine-based reward
- Discussion
- Pathways and systems involved in nicotine dependence
- Discussion
- Localizing tobacco dependence pathways with functional brain imaging
- Discussion
- Pharmacogenetic approach to nicotine dependence treatment
- Discussion
- Pharmacogenomics and smoking cessation
- Discussion
- General discussion II. Power in studies
- Receptor desensitizadon
- What limits the efficacy of current nicotine replacement therapies?
- Discussion
- Exploring behavioural mechanisms of nicotine replacement therapy for smoking cessation
- Discussion
- Modifying the metabolism of nicotine as a therapeutic strategy
- Discussion
- Challenges in discovery and development of pharmacotherapies for tobacco addiction
- Discussion
- Final discussion: Nicotine comorbidity
- Animal models
- Index of contributors
- Subject index
